Answers are grounded in this paper and cite their sources.
Multiple benign hepatic cysts are frequently detected incidentally, yet their management becomes challenging when lesions are multifocal, symptomatic, or difficult to distinguish from polycystic liver disease (PLD) and other cystic entities. This review summarizes the pathophysiology, clinical course, imaging evaluation, and current therapeutic options for multiple benign nonparasitic hepatic cysts, with emphasis on symptom-directed management. Ultrasound remains the first-line diagnostic modality, while cross-sectional imaging is reserved for atypical or complex lesions and for assessment of disease distribution. Asymptomatic simple cysts generally require neither intervention nor routine surveillance, whereas symptomatic disease may be treated with percutaneous aspiration and sclerotherapy, laparoscopic fenestration, or, in selected cases, hepatic resection. In diffuse symptomatic PLD, somatostatin analogues and, rarely, liver transplantation may be considered. To support individualized treatment planning, we propose a distribution-based framework classifying disease into four anatomical patterns: unilobar limited, asymmetric bilobar with a dominant lobe, bilobar symmetric, and diffuse scattered cysts. This framework, defined by hierarchical anatomical criteria and complemented by liver volumetry, is intended to complement established guidelines and polycystic liver disease classifications by linking cyst distribution and symptom burden with the least invasive effective treatment strategy.
No takes yet. Share an insight, caveat, or question.
Paramythiotis et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: